Month: September 2025

DIAGNOS Announces Private Placement

Written by Customer Service on September 3, 2025. Posted in Public Companies.

BROSSARD, Quebec, Sept. 03, 2025 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), announces a non-brokered private placement (“Private placement”) of 10 units (each a “Unit”) to be issued at a price of $10,000 per Unit for gross proceeds of $100,000. Each Unit consists of: (i) One $10,000 unsecured convertible debenture (each a “Debenture”), and (ii) 10,000 stock warrants (each a “Warrant”).Each Debenture has a term of 12 months (the “Term”) and bears interest at the annual rate of 10%, payable in cash. At the option of the holder of the Debenture, the principal amount may be converted, at any time during the Term, into common shares...

SEGG Media Reenters U.S. Lottery Market with Lottery.com Affiliate Initiative and Players Rewards Program

Written by Customer Service on September 3, 2025. Posted in Public Companies.

Nationwide Excitement over $1.3 Billion Jackpot Accelerates Company’s US Reintroduction of Lottery.com Brand FORT WORTH, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) — SEGG Media Corporation (NASDAQ: SEGG, LTRYW) (“SEGG Media” or the “Company”), a sports, entertainment and gaming conglomerate that owns Sports.com, Concerts.com, and Lottery.com, today announced its plans for reentry into the domestic U.S. lottery market. As part of this reintroduction of the Lottery.com brand, the Company will launch a nationwide lottery rewards program and has started the process to serve as an official affiliate partner of state-operated iLottery programs in Pennsylvania, Virginia, and Michigan. Upon approval, the affiliate marketing programs will mark a return to the U.S. lottery sector for the Lottery.com brand and position the company as a key player...

Clover Health CEO Andrew Toy Testifies Before Congress on the Transformative Role of AI in Healthcare, Highlights how Clover is Leading the Way

Written by Customer Service on September 3, 2025. Posted in Public Companies.

WASHINGTON, D.C., Sept. 03, 2025 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) – Clover Health CEO Andrew Toy today had the honor to deliver testimony before the U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health, positioning Clover as a national leader in AI-enabled healthcare transformation. In his testimony, Andrew highlighted how Clover’s proprietary AI platform empowers physicians to deliver more personalized, timely care at the point of service, particularly to seniors in rural and other underserved communities. Motivated by a personal mission to improve care delivery following the loss of his father to complications from uncoordinated care, Andrew shared how Clover uses technology to simplify the healthcare experience and...

374Water to Attend Upcoming Investor Conferences in September

Written by Customer Service on September 3, 2025. Posted in Public Companies.

Lake Street 9th Annual Best Ideas Growth (BIG9) Conference, H.C. Wainwright 27th Annual Global Investment Conference, and Gabelli Funds’ 3rd PFAS Symposium DURHAM, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) — 374Water Inc. (NASDAQ: SCWO) (“374Water”) (the “Company”), a global leader in organic waste destruction technology and services for the municipal, federal, and industrial markets, today announced that management will attend the Lake Street 9th annual Best Ideas Growth (BIG9) Conference, the H.C. Wainwright 27th Annual Global Investment Conference, and the Gabelli Funds’ 3rd PFAS Symposium in September 2025. 374Water President and CEO Chris Gannon and CFO Russell Kline will attend the Lake Street 9th Annual Best Ideas Growth (BIG9) Conference on September 11, and the H.C. Wainwright 27th Annual Global Investment Conference which...

Almadex Provides Exploration and Drilling Update and Plans for Remainder of 2025

Written by Customer Service on September 3, 2025. Posted in Public Companies.

VANCOUVER, British Columbia, Sept. 03, 2025 (GLOBE NEWSWIRE) — Almadex Minerals Ltd. (“Almadex” or the “Company”) (TSX-V: “DEX”) is pleased to provide an update on recent and planned exploration activity for the remainder of 2025. Drilling ActivitiesAs previously announced upon commencement (see Almadex news release of June 17, 2025), Almadex has now completed the drilling of two diamond drill holes at its wholly owned porphyry lithocap target on the Paradise Project, Nevada. Drilling of a third hole will commence shortly. Assays are pending from this program. When complete results are received and interpreted the Company will provide an update. Almadex also anticipates that a first pass drilling program on one of the projects optioned by Azucar Minerals (see Almadex news release of May 1, 2025) upon approval...

PharmaCorp to Acquire Two Pharmacies in Western Canada

Written by Customer Service on September 3, 2025. Posted in Mergers And Acquisitions.

SASKATOON, Saskatchewan, Sept. 03, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has entered into definitive share purchase agreements, each dated August 29, 2025 (the “Agreements”), to acquire from the same arm’s length vendors (the “Vendors”) a 100% interest in two PharmaChoice Canada bannered pharmacies located in Western Canada, one of which includes the associated lands and building (the “Acquisitions”). The aggregate purchase price for the Acquisitions is $3,400,000, subject to customary adjustments (the “Purchase Price”). In accordance with the Agreements, 75% of the Purchase Price will be satisfied with cash on hand and 25% will be satisfied by the issuance of common shares of PharmaCorp (the “Common Shares”). The deemed price for the Common Shares...

EPH European Property Holdings PLC Profit / Loss Warning – EPH expects net profit in its consolidated accounts for the 1HY 2025 compared to the previous year

Written by Customer Service on September 3, 2025. Posted in Earnings Releases And Operating Results.

03 September 2025, Limassol, Cyprus / Ad hoc announcement pursuant to Art. 53 LR EPH European Property Holdings PLC (“EPH”, the “Company”) would like to announce that the Company expects a net profit of approximately EUR 4-5 million for the first half year 2025, compared to a net loss of EUR 13.89 million for the same period a year earlier. The main factor behind this positive change in financial results is a gain on revaluation of investment properties of approximately EUR 3 million, recognized in the reporting period, resulting primarily from a slight increase in market rental rates and stabilization of discount and capitalization rates at the level of YE 2024. In HY 2024, EPH recognised a loss of EUR 20 million on revaluation of investment properties as a result of rising capitalization and discount rates during that period. The revenue...

ChipFoundry Acquires Efabless Assets to Propel Custom Silicon Innovation

Written by Customer Service on September 3, 2025. Posted in Mergers And Acquisitions.

SAN CARLOS, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — Umbralogic Technologies LLC, operating as ChipFoundry, today announced the successful acquisition of Efabless’ intellectual property and technology assets, including a portfolio of 15 issued patents and 3 pending applications. This strategic purchase strengthens ChipFoundry’s commitment to making custom silicon accessible to a broader market of innovators, researchers, and educators worldwide. ChipFoundry provides a platform designed to democratize silicon chip design and manufacturing by lowering the barriers to custom chip development. It achieves this by providing affordable prototyping and fabrication, standardized design templates, and a collaborative ecosystem that empowers product innovators, startups, researchers, and educational institutions to bring their silicon...

Microbix Hosts Ontario Minister Stephen Crawford

Written by Customer Service on September 3, 2025. Posted in Public Companies.

Site Visit & Discussions at Biotech Manufacturing Facilities in Mississauga MISSISSAUGA, Ontario, Sept. 03, 2025 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces its hosting of the Honourable Stephen Crawford, Ontario’s Minister of Public and Business Service Delivery and Procurement, for a site visit to tour the company’s advanced biotechnology development and manufacturing facilities and discuss how next generation diagnostics can improve health outcomes while reducing healthcare costs for Ontarians. The Province of Ontario has been a strong supporter of Microbix in recent years, with over C$ 2.0 million of grant funding from its Ontario Together Funds (OTF & OTF2). Those successful initiatives have helped build state-of-the-art...

Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves’ Disease Patients

Written by Customer Service on September 3, 2025. Posted in Public Companies.

First-ever potentially disease-modifying therapy for uncontrolled Graves’ disease patients Of 21 patients who entered the six-month off-treatment follow-up period, ~80% (17/21) demonstrated response, resulting in normal thyroid function (T3 and T4 less than the upper limit of normal) at the end of the six-month follow-up period Of the 17 responders to therapy, ~50% (8/17) achieved anti-thyroid drug (ATD) free remission at six months following end of batoclimab treatment Two potentially registrational trials for IMVT-1402 in Graves’ disease are currently enrolling with topline readouts expected in 2027 Roivant to host investor call to discuss these updates today, September 3, 2025, at 4:30 p.m. EDTNEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling...

Month: September 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals